Protein kinase deficient, immunologically active CMVpp65 mutants

   
   

This invention relates to mutated CMVpp65, a viral structural protein which activates cell mediated immunity in humans infected with CMV. The mutations remove undesirable protein kinase activity naturally present in the protein and make it suitable for the production of both DNA and protein vaccines. Therefore, the invention provides proteins and DNAs, as well as vaccines comprising the proteins and DNAs, including cellular vaccines and vectors. Other embodiments of the invention relate to methods of enhancing immune response and vaccinating against CMV, including gene therapy methods and vectors.

 
Web www.patentalert.com

< Antigenically reactive regions of the hepatitis a virus polyprotein

< Cytotoxic T-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy

> Clam shell blood reservoir holder with index line

> Motilin Homologs

~ 00153